{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Xiaolei Wu"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0006025000"],"submitter_email":["xiaolei.wu@proteint.com"],"submitter_affiliation":["Tianjin Key Laboratory of Clinical Multiomics"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"A Proteomic Approach to Distinguish Leptomeningeal Metastasis in Lung Adenocarcinoma Patients","description":"Based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) investigation of cere-brospinal fluid (CSF), we prospectively characterized proteins in CSF samples of 36 lung adeno-carcinoma patients, including 19 LM patients and 17 non-LM patients. We identified 290 signifi-cantly differentially expressed proteins (DEPs). In this study, we applied proteomic methods to develop a model to assist diagnosis of LM in lung adenocarcinoma cancer and identified an important biomarker, TSP-2.","dates":{"publication":"Mon Mar 20 00:00:00 GMT 2023"},"accession":"PXD040965","cross_references":{"TAXONOMY":["9606"]}}